Clinical Trial Update: Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a stem cell gene therapy targeting X-linked severe combined immunodeficiency. The study status indicates the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency
• X-linked Severe Combined Immunodeficiency

Drugs mentioned

• Stem Cell Gene Therapy for XSCID

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Severe Combined Immunodeficiency | Phase 1 | Status: COMPLETED